Recently, anti-nephrin antibodies have been identified in 11 (79%) patients with recurrence of primary FSGS after kidney transplantation [4], further adding evidence to the theory of a continuous disease spectrum of MCD and FSGS, and that pathobiology needs to be re-written based on antibody detection. The gene discussed is NPHS1; the disease is focal segmental glomerulosclerosis.